News Links
Research News From November 30, 2016
Pharmacokinetic and Pharmacodynamic Properties of Faster-Acting Insulin Aspart versus Insulin Aspart Across a Clinically Relevant Dose Range in Subjects with Type 1 Diabetes Mellitus. A Comparison of Pharmacokinetic and Pharmacodynamic Properties Between Faster-Acting Insulin Aspart and Insulin Aspart in Elderly Subjects with Type 1 Diabetes Mellitus. A parasite-derived 68-mer peptide ameliorates autoimmune disease in murine models of Type 1 diabetes and multiple sclerosis. Oxygenation of the Intraportally Transplanted Pancreatic Islet. Free full text available in HTML and PDF formats.
Read MorePress Releases for November 23, 2016
Dexcom One Step Ahead Foundation: A Dexcom Employees Foundation Awards First Grants to Diabetes Advocacy Organizations. Livongo Glucose Meter Delivers First Over-the-Air Capabilities to Industry.
Read MorePopular Press for November 23, 2016
When it’s not just the flu: Kids with Type 1 diabetes often misdiagnosed due to the rapid onset of common symptoms. How to speak to someone living with diabetes, without being rude. NASCAR racer driven to win despite Type 1 Diabetes. Reds’ All-Star powering through Type 1 diabetes. Fellow diabetics help boy’s cycling dream. How to help your child manage their diabetes. Type 1 diabetes diagnosis alters life’s journey. Addie Hilger: We’re not going to let diabetes stop us. A family affected by type 1 diabetes doesn’t let the disease stand in their way. A type one diabetic shares his […]
Read MoreLegislative and Policy News for November 23, 2016
American Diabetes Association calls on Congress to hold hearings on insulin prices. See also American Diabetes Association Board of Directors’ Resolution: Insulin Affordability.
Read MoreCeliac News for November 23, 2016
No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients with Symptomatic Celiac Disease. Celiac Disease and H. Pylori Infection in Children: Is there any Association?
Read MoreDaily Care News for November 23, 2016
Liraglutide as adjunct to insulin treatment in type 1 diabetes does not interfere with glycemic recovery or gastric emptying rate during hypoglycemia: a randomized, placebo-controlled, double-blind, parallel-group study. Reduced prevalence of impaired awareness of hypoglycemia in a population-based clinic sample of youth with type 1 diabetes. Clinical Outcomes After 1 Year of Augmented Insulin Pump Therapy in Patients with Diabetes in a Specialized Diabetes Center in Medellín, Colombia. Psychosocial Care for People With Diabetes: A Position Statement of the American Diabetes Association. Disordered Eating Behaviors in Emerging Adults With Type 1 Diabetes: A Common Problem for Both Men and Women. […]
Read MoreResearch News From November 23, 2016
Imbalance of bacteriome profiles within the Finnish Diabetes Prediction and Prevention study: Parallel use of 16S profiling and virome sequencing in stool samples from children with islet autoimmunity and matched controls. Circulating microRNA levels predict residual beta cell function and glycaemic control in children with type 1 diabetes mellitus. A comprehensive microbiological safety approach for agarose encapsulated porcine islets intended for clinical trials.
Read MorePress Releases for November 16, 2016
With Health Canada approval, Dexcom G5® Mobile CGM System is the First and Only Medical Device in North America for Making Daily Diabetes Decisions Without Painful Fingersticks. NIH-funded International Diabetes Closed Loop (IDCL) Trial to Combine Technologies from Tandem Diabetes Care, Dexcom and TypeZero. BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery.
Read More